Low FAM210B levels were observed in 50% (32 of 64) of HCC samples, whereas only 7.8% (5 of 64) of adjacent normal samples showed low levels of this (p < 0.001) (Figure 2B,C). This evidence concerns the gene MIMS2 and hepatocellular carcinoma.